rVSV-Zebov GP vaccine

Phase 2Vaccine

NNational Institute of Allergy and Infectious Diseases (NIAID)

rVSV-Zebov GP vaccine is one of 16 biologic programs targeting Stomatitis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

StomatitisActive, not recruiting

StomatitisPhase 2

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Stomatitis

#DrugCompanyPhaseTrials

DATROWAY

Daiichi Sankyo

Approved

1 2

Mycostatin

GGood Molecules, LLC

Approved

1 3

Neo-Synephrine

EExela Pharma Sciences, LLC.

Xylocaine

Afinitor

1 6

Decadron

AAspen Global Incorporated

Phase 3

2 7

Kepivance

SSwedish Orphan Biovitrum

Thalomid

1 9

Dexamethasone Mouthwash

WWoman's

Approved

1 10

Valtrex

GGlaxo Dba Glaxosmithkline

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Stomatitis1 trial

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT02788227·99 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for rVSV-Zebov GP vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — rVSV-Zebov GP vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for rVSV-Zebov GP vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Institute of Allergy and Infectious Diseases (NIAID) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 2[1]
Company: NNational Institute of Allergy and Infectious Diseases (NIAID)

rVSV-Zebov GP vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Stomatitis1 trial

References

Drug Info

Quick Facts

Related News